Publication: 241

High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.

Citation:: J Clin Oncol vol 25 (22) 3337-43

Year:: 2007
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:

Parents:: 529 654
Children:: None

Program:: TRP
Primary Committee:: Leuk Corr Sci
Sec. Committees:

Pharmas:
Grants:: CA089341, CA09512, CA101140, CA102031, CA16058, CA31946, CA77658, CA90469, CA96887, CA98933

Corr. Author:
Authors:: Guido Marcucci Kati Maharry Susan P Whitman Tamara Vukosavljevic Peter Paschka Christian Langer Krzysztof Mrózek Claudia D Baldus Andrew J Carroll Bayard L Powell Jonathan E Kolitz Richard A Larson Clara D Bloomfield

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-19808, CALGB-20205, CALGB-20502, CALGB-8461, CALGB-9621, CALGB-9665
Phases:: 1, 3, N/A

Keywords:: Adult, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, DNA-Binding Proteins, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Reverse Transcriptase Polymerase Chain Reaction, Risk Assessment, Statistics, Nonparametric, Stem Cell Transplantation, Survival Analysis, Trans-Activators, Transcriptional Regulator ERG, Up-Regulation